LCB SA
Dissolution judiciaire ou nullitéThe score of LCB shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2023
Change 2020 → 2023: Equity +12 % Total assets -58 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LCB's annual accounts
Filed annual accounts
- Year ended 31 Dec 2023filed on 14 Nov 2024
- Year ended 31 Dec 2022filed on 07 Feb 2024
- Year ended 31 Dec 2021filed on 05 Dec 2022
- Year ended 31 Dec 2020filed on 30 Oct 2023
- Year ended 31 Dec 2019filed on 30 Oct 2020
LCB's financial analysis
- Solvency62.5%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LCB
LCB's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0829.395.530
- VAT number
- BE0829395530
- Peppol
- Not found on Peppol as of 09 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 15 Sep 2010
- Registered office
- 7850 Enghien
- Latest accounts
- 2023 · filed on 14 Nov 2024
- Activity
- Research and experimental development on biotechnology (NACE 72101)
LCB (SA) has been based in Enghien since 2010, active in: research and experimental development on biotechnology. For 2023, it reports a net loss of 119,528 € and equity of 664,101 €; its revenue is not published. Its solvency stands at 62.5%, above the median of its sector (58.2%).
Companies similar to LCB
Companies in the same business, of comparable size and area, outside its group.
- Nyemb Research and experimental development on natural sciences and engineering Tournai · balance sheet €1.15m
- Grand Medical (Europe) Research and experimental development on natural sciences and engineering Niel · balance sheet 135,260 €
- Dokter Fries Claerhout Research and experimental development on natural sciences and engineering Poperinge · balance sheet 906,181 €
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- ProtonW.be Research and experimental development on natural sciences and engineering Charleroi · balance sheet €1.27m
- IR 4 Research and experimental development on natural sciences and engineering Auderghem · balance sheet 865,084 €
- ILiAD Biotechnologies Research and experimental development on natural sciences and engineering Ghent · balance sheet €1.06m
- Temple OrthoBiologics Research and experimental development on natural sciences and engineering Liège · balance sheet 692,165 €
Frequently asked questions about LCB
What is the revenue of LCB?
LCB files its accounts in a format where revenue is optional: it is not published for 2023.
What is the VAT number of LCB?
In Belgium, the VAT number is the company number prefixed with BE: BE0829395530 for LCB, if the company is VAT-registered. Its company number (CBE) is 0829.395.530.
Where is the registered office of LCB?
According to the CBE register, the registered office of LCB is in 7850 Enghien.
What is the equity of LCB?
At the close of the 2023 financial year, the equity of LCB amounts to 664,101 €, a solvency of 62.5% of total assets.
Who manages LCB?
The register lists 3 active mandates at LCB. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LCB
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →